Jay A. Fishman, M.D., FACP, FAST, FIDSA is Professor of Medicine at Harvard Medical School, Director of the Transplant Infectious Diseases Program at the Massachusetts General Hospital (MGH), and Associate Director of the MGH Transplant Center.  Dr. Fishman completed medical school at Johns Hopkins University School of Medicine, internal medicine training and Infectious Disease Fellowship at MGH, and Fellowships in Molecular Biology and Genetics at MGH and Harvard Medical School.  Dr. Fishman established the Transplant and Immunocompromised Host Program of the MGH, the first such training program worldwide which has trained many leaders in this field.  He established Transplant Infectious Disease as an essential component of Transplant programs.  His clinical expertise spans infectious diseases and immunology of solid organ and stem cell transplant recipients and has defined approaches to managing infectious risk in allo- and xenotransplantation.  His research defined the use of ganciclovir for cytomegalovirus infection in transplant recipients.  His background in immunology, virology and molecular biology led to the cloning of surface antigens of human Pneumocystis, and to studies of porcine cytomegalovirus and porcine endogenous retrovirus (PERV) in xenotransplantation.  He has over 300 peer-reviewed publications and is internationally recognized as a clinician-educator and scientist. He is Past-President of the American Society of Transplantation and is President-elect of the International Xenotransplantation Association.  He has received career achievement awards from AST and TTS.